Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Jingtao Gao

Jingtao Gao

report china

National Clinical Centre on Tuberculosis, China CDC
Beijing Chest Hospital

Jingtao Gao, PhD, is the deputy director of the Managing Office of Clinical Center on TB, China CDC. She has been engaging in the field of TB prevention and control for 12 years. She obtained her master’s degree in internal medicine from Peking Union Medical University in 2008. She got her PhD in internal medicine from Beijing Tuberculosis and Thoracic Tumor Research Institute in 2015.

Jingtao Gao has worked at Keio University in Japan as an advanced visiting scholar from 2013-2015 on respiratory research. Her special interests include TB clinical practice, programmatic management and research activities on drug-resistant TB treatment. 

Jingtao Gao is the key member of China’s TB Clinical Trial Consortium (CTCTC), and is engaged in the planning, coordination and development of research activities of the consortium. In addition, she was involved in mentoring and supporting consortium investigators for research data management and manual writing.

Her practice and experience include over 10 national level TB scientific studies and projects, such as – The 11th-Five-Year National Science and Technology Major Project on drug resistance emergence mechanism and early warning model building, sponsored by the Ministry of Science and Technology of the People’s Republic of China (MOST). This was followed by – two 12th-Five-Year Projects on new treatment regimens for drug-resistant TB and efficacy of ultra-short course chemotherapy for newly diagnosed smear-positive drug-susceptible TB. She was designated as PI of the 13th-Five-Year Projects on exploring the mechanism of TB recurrence after treatment success of MDR-TB patients and also served as the Co-PI of Regional Prospective Observational Research in Tuberculosis (RePORT) which is a multi-country cohort study. For the last 3 years, she was designated as the director of the department of the clinical trial of Innovation Alliance on Tuberculosis Diagnosis and Treatment (Beijing) responsible for protocol design, EDC development, data management and research quality control in several phase III-IV clinical trials of the new anti-TB drugs.